Search results for "NAFLD"
NAFLD progression associated with increased mortality risk
Patients with stage F4 nonalcoholic fatty liver disease (NAFLD) have significantly increased risk for liver-related complications, type 2 diabetes, and all-cause mortality compared to those with earlier stages, an observational prospective study found.
https://gastroenterology.acponline.org/archives/2021/10/22/3.htm
22 Oct 2021
Biopsy-proven NAFLD associated with higher rates of MACE
Patients in a Swedish study whose nonalcoholic fatty liver disease (NAFLD) was confirmed on biopsy were more likely to experience incident major adverse cardiovascular events (MACE).
https://gastroenterology.acponline.org/archives/2021/09/24/2.htm
24 Sep 2021
Watch out for NAFLD, treat ASAP
Identifying nonalcoholic fatty liver disease (NAFLD) in the primary care setting and deploying effective interventions early can help prevent the slowly progressive disease from becoming an even bigger problem.
https://gastroenterology.acponline.org/archives/2021/04/23/6.htm
23 Apr 2021
Half of overweight, obese adults may have fatty liver disease
The global prevalence of metabolic dysfunction-associated fatty liver disease, a newly proposed term for nonalcoholic fatty liver disease, is “astonishingly high,” the authors of a recent meta-analysis found.
https://gastroenterology.acponline.org/archives/2021/02/26/3.htm
26 Feb 2021
Prevalence of liver fibrosis in diabetes suggests need for earlier intervention, study finds
The prevalence of any suspected liver fibrosis in patients with diabetes was 21% in a recent study, leading the authors to call for more aggressive screening in patients with obesity and diabetes.
https://gastroenterology.acponline.org/archives/2021/01/22/3.htm
22 Jan 2021
Spotlight on lean NAFLD
Recent studies looked at the increasing prevalence of nonalcoholic fatty liver disease (NAFLD) in patients without overweight or obesity and compared clinical characteristics of these patients with both healthy controls and patients with obesity and NAFLD.
https://gastroenterology.acponline.org/archives/2020/07/24/5.htm
24 Jul 2020
Risk and severity of NAFLD differ in men and women
Women have a significantly lower risk of developing nonalcoholic fatty liver disease (NAFLD) but a higher risk of developing advanced fibrosis from NAFLD, according to a systematic review and meta-analysis.
https://gastroenterology.acponline.org/archives/2020/05/22/3.htm
22 May 2020
Score predicts hepatic decompensation among patients with NAFLD
Age, presence of diabetes, and platelet count were significant predictors of hepatic events up to 12 years from the time of nonalcoholic fatty liver disease (NAFLD) diagnosis, a retrospective study found.
https://gastroenterology.acponline.org/archives/2020/03/27/1.htm
27 Mar 2020
Experts go ‘Beyond the Guidelines' to debate screening, management of NAFLD
Hepatologists from Beth Israel Deaconess Medical Center and University of Michigan Medical Center offered differing opinions on screening and management for nonalcoholic fatty liver disease (NAFLD).
https://gastroenterology.acponline.org/archives/2019/08/23/8.htm
23 Aug 2019
Weight loss interventions may improve biomarkers of liver disease in NAFLD
In a meta-analysis of 22 studies in patients with nonalcoholic fatty liver disease (NAFLD), weight loss interventions were associated with improvements in alanine aminotransferase level, liver steatosis, histologic NAFLD activity score, and nonalcoholic steatohepatitis.
https://gastroenterology.acponline.org/archives/2019/07/26/3.htm
26 Jul 2019